These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 17457655)
1. Mathematical model of BCG immunotherapy in superficial bladder cancer. Bunimovich-Mendrazitsky S; Shochat E; Stone L Bull Math Biol; 2007 Aug; 69(6):1847-70. PubMed ID: 17457655 [TBL] [Abstract][Full Text] [Related]
2. Mathematical model of pulsed immunotherapy for superficial bladder cancer. Bunimovich-Mendrazitsky S; Byrne H; Stone L Bull Math Biol; 2008 Oct; 70(7):2055-76. PubMed ID: 18716846 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine. Lee CF; Chang SY; Hsieh DS; Yu DS J Urol; 2004 Mar; 171(3):1343-7. PubMed ID: 14767345 [TBL] [Abstract][Full Text] [Related]
4. A mathematical model of combined bacillus Calmette-Guerin (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer. Bunimovich-Mendrazitsky S; Claude Gluckman J; Chaskalovic J J Theor Biol; 2011 May; 277(1):27-40. PubMed ID: 21334346 [TBL] [Abstract][Full Text] [Related]
5. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity. Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010 [TBL] [Abstract][Full Text] [Related]
6. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. Yutkin V; Pode D; Pikarsky E; Mandelboim O J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285 [TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guérin immunotherapy for superficial bladder cancer. New prospects for an old warhorse. O'Donnell MA; DeWolf WC Surg Oncol Clin N Am; 1995 Apr; 4(2):189-202. PubMed ID: 7796280 [TBL] [Abstract][Full Text] [Related]
8. [Cytokine therapy of superficial bladder carcinoma. Mechanisms of action and results of therapy]. Otto T; Kälble T Urologe A; 1994 Nov; 33(6):540-6. PubMed ID: 7817454 [TBL] [Abstract][Full Text] [Related]
9. Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. Böhle A; Brandau S J Urol; 2003 Sep; 170(3):964-9. PubMed ID: 12913751 [TBL] [Abstract][Full Text] [Related]